Harvard Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HBIO and other ETFs, options, and stocks.

About HBIO

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. 

CEO
John D. Duke
CEOJohn D. Duke
Employees
339
Employees339
Headquarters
Holliston, Massachusetts
HeadquartersHolliston, Massachusetts
Founded
1901
Founded1901
Employees
339
Employees339

HBIO Key Statistics

Market cap
21.28M
Market cap21.28M
Price-Earnings ratio
-0.37
Price-Earnings ratio-0.37
Dividend yield
Dividend yield
Average volume
431.28K
Average volume431.28K
High today
$0.5252
High today$0.5252
Low today
$0.459
Low today$0.459
Open price
$0.48
Open price$0.48
Volume
487.01K
Volume487.01K
52 Week high
$0.9458
52 Week high$0.9458
52 Week low
$0.2813
52 Week low$0.2813

Stock Snapshot

The current Harvard Bioscience(HBIO) stock price is $0.50, with a market capitalization of 21.28M. The stock trades at a price-to-earnings (P/E) ratio of -0.37.

On 2026-03-14, Harvard Bioscience(HBIO) stock moved within a range of $0.46 to $0.53. With shares now at $0.50, the stock is trading +8.2% above its intraday low and -5.4% below the session's peak.

Trading activity shows a volume of 487.01K, compared to an average daily volume of 431.28K.

The stock's 52-week range extends from a low of $0.28 to a high of $0.95.

The stock's 52-week range extends from a low of $0.28 to a high of $0.95.

HBIO News

TipRanks 2d
Harvard Bioscience price target lowered to 60c from $2 at Benchmark

Benchmark lowered the firm’s price target on Harvard Bioscience (HBIO) to 60c from $2 and keeps a Speculative Buy rating on the shares. The timing of recovery c...

TipRanks 2d
Harvard Bioscience Earnings Call Signals Gradual Recovery

Harvard Bioscience ((HBIO)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 70% Off TipRanks Premium Unlock hedge fund-level d...

Seeking Alpha 2d
Harvard Bioscience outlines 2026 guidance with 2%–4% revenue growth and high-margin focus following structural improvements

Earnings Call Insights Harvard Bioscience outlines 2026 guidance with 2%–4% revenue growth and high-margin focus following structural improvements Mar. 12, 2026...

Harvard Bioscience outlines 2026 guidance with 2%–4% revenue growth and high-margin focus following structural improvements

More HBIO News

TipRanks 5d
Harvard Bioscience Updates Executive Contracts and Finance Leadership

An update from Harvard Bioscience ( (HBIO) ) is now available. On March 6, 2026, Harvard Bioscience, Inc. amended and restated the employment agreement for Chi...

People also own

Based on the portfolios of people who own HBIO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.